Regeneron, DB-OTO results in the New England Journal of Medicine, investor release (October 2025) (sponsor’s release about the paper)

https://investor.regeneron.com/news-releases/news-release-details/db-oto-results-new-england-journal-medicine-showcase-dramatic

Authors. Regeneron

Venue. investor release (sponsor’s release about the paper)

How the Institute flags it

frontier 6 times

Cited on 6 pages

• Biological Enhancement
• Genetic Engineering
• Neurogenetics
• Neuroplasticity Engineering
• Precision Medicine
• Sensory Restoration